Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Gastroenterology. 2013 Apr 2;145(1):138–148. doi: 10.1053/j.gastro.2013.03.048

Table 1.

Summary of Clinical Phenotype of 13 Subjects with PCSK1 Mutations

ID # 1 2 3 4 5a 5b 6a 6b 7 8 9 10 11 Summary
Ethnicity Hispanic Indian Turkish Turkish African African Arab Arab Turkish Arab Turkish Turkish Canadian Diverse
Sex M M F M M M M M M M M F M 11 of 13 male
Outcome; Age Alive; 7.5 yo Alive; 6 yo Alive; 15 yo Dead @ 8 mo; sepsis Alive; 3.7 yo Alive; 9.3 yo Alive; 12.8 yo Alive; 2.9 yo Dead @ 15 mo; sepsis Alive; 5.5 yo Alive; 3.8 yo Alive; 3.0 yo Alive; 17 yo 11 of 13 alive χ 7.7 +/−4.8
Consanguinity Yes Yes Yes Yes No No Yes Yes Yes Yes Yes Yes No Yes, 12 of 13
Family history No No No No Yes; #87b Yes; #87a Yes, 2; 1 died & #113 Yes, 2; 1 died & #88 No Yes; 1 died @ 5 yo No Yes; died No Yes, 4 of 12
Birth Wt Kg 3.85 3.3 3.3 3.1 3.55 3.7 3.13 2.95 3.2 3.1 3.8 3.6 3.5 χ3.4+/−0.3
Age presented 3 wk 1 wk 1 wk 1 wk 1 wk 1 wk 2 wk 1 wk 4 wk 8 wks 3 wk 2 wk 2 wk χ 2.3 +/−1.9
Generalize malabsoprtion Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes, 13 of 13
Intest. Biopsy; Normal Yes Yes No; mild villus atropy Yes No; villus atropy; eos Not done Yes Yes Yes Yes Yes Yes Yes Yes, 0 of 12 normal
Chronic IV Nut (age start; end) Yes (1 to 16 mo) Yes (3 to 12 mo) Yes (10 to 34 mo) Yes (4 to 8 mo) Yes (1 to 20 mo) Never treated w/ IV Nut Yes (1.5 to 11 mo) Yes (1 to 12 mo) Yes (3 to 15 mo) Yes (6 to 14 mo) Yes (10 to 23 mo) Yes (1 to 12 mo) Yes (1 to 12 mo) Yes, 12 of 13
Early growth:
FTT/age; WT Z score
Yes/2mo; WT Z −1.3 Yes/2mo; WT Z −2.1 Yes/10mo; WT Z −6.56 Yes/4 mo; WT Z −5.63 Yes/1 wk; WT Z−1.7 Yes/6 mo; WT Z−6.6 Yes/2 mo; WT Z−2.66 Yes/2 wk; WT Z−2.5 Yes/3 mo; WT Z−3.24 Yes/2 mo; WT Z −4.0 Yes/4 mo; WT Z−1.9 Yes/2.5 mo; WT Z−2.24 Yes/1 mo; WT Z−3.15 Yes, 13 of 13
χ −3.35+/−1.8
Late growth:
Obese/age
WT Z score
HT Z score
Yes/7.7 yo; BMI Z+2.4
WT Z+1.81
HT Z−1.4
N/A Yes/15yo; BMI Z+1.7
WT Z+1.0
HT Z−1.78
N/A Yes/3.7yo; BMI Z+2.7
WT Z+1.4
HT Z−0.7
Yes/9.3 yo; BMI Z+2.33
WT Z+2.15
HT Z−0.21
Yes/12.8yo; BMI Z+2.6
WT Z +2.5
HT Z−0.6
Yes/2.9yo; BMI Z+2.55
WT Z+0.0
HT Z−2.8
N/A No/5.5yo; BMI Z+0.2
WTZ −1.21
HT Z −1.26
Yes/3.5yo; BMI Z+3.62
WT Z +2.18
HT Z −0.68
Yes/2.4 yo; BMI Z+3.43
WT Z +2.7
HT Z−0.1
Yes/17 yo; BMI Z+2.36
WTZ+2.03
HT Z−1.12
Yes, 9 of 10
BMI +2.5+/−
0.9 WT +1.5+/−
1.2 HT−1.0+/−
Proinsulin ND ND ND ND Elevated Elevated Elevated Elevated ND Elevated Elevated ND Elevated 7 of 13
Postprandial hypoglycemia Yes Yes Yes No Yes Yes No No Yes No Yes Yes No 8 of 13
Polydipsia& Polyuria Yes Yes Yes No Yes Yes Yes No Yes Yes Yes Yes Yes 11 of 13
Diabetes Insipidus confirmed; Age, treated Yes, @ 18 mo; DDAVP N/A Yes, @3.5 yo; DDAVP N/A N/A Yes, @ 13.5 mo; DDAVP Yes, @ 1 mo; DDAVP N/A N/A No Yes, @ 13 mo; DDAVP Yes, @ 19 mo; DDAVP Yes, @3 yo; not responsive to DDAVP 7 of 13
Hypogonadism Micropenis N/A Yes, delay puberty N/A No Micropenis; hypospadias No No No No No N/A Micropenis; delay puberty 4 of 13
Hypoadrenalism confirmed; Age, treated Yes, @6.5 yo N/A Yes, @5.5 yo No Yes, @12mo Yes, @6mo Yes, @1mo Yes, @ 3 mo N/A No Yes, @ 14 mo; hydrocortisone with stress Yes, @ 19 mo; hydrocortisone No 8 of 13
GH deficiency confirmed; Age, treated N/A N/A Yes, @5.5 yo N/A No No Yes, @9.5yo Yes, @2.5 yo N/A No No No Yes, @ 14 yo 4 of 13
Hypothyroid confirmed; Age, treated Yes, @6.5 yo N/A Yes, @5.5 yo No No No Yes, @ 1 mo Yes, @ 3 wk Yes, @ 1 mo Yes, @ 4 mo No Yes, 29 mo Yes, @ 17 yo 8 of 13

N/A, not assessed; Yes, confirm symptom or test; No, does not have symptom, or the test was negative; yo (years-of-age); mo (months-of-age).